Medical treatment of rosacea with emphasis on topical therapies

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 1, 2004, Pages 5-13

  Del Rosso, James Q ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Dermatosis; Erythema; Rosacea; Therapy

Indexed keywords

AZELAIC ACID; BENZOYL PEROXIDE; BIFONAZOLE; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; KETOCONAZOLE; METRONIDAZOLE; MINOCYCLINE; OXYTETRACYCLINE; PERMETHRIN; RETINOIC ACID; RETINOIC ACID DERIVATIVE; SULFACETAMIDE; SULFUR; TETRACYCLINE DERIVATIVE; TOPICAL AGENT;

ADULT; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT SENSITIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RETENTION; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; GROUPS BY AGE; HUMAN; MEDICAL LITERATURE; PAPULE; PATHOGENESIS; PHOTODERMATOSIS; PHOTOTOXICITY; PRURITUS; PUSTULE; REMISSION; REVIEW; ROSACEA; SENSORY DYSFUNCTION; SKIN ALLERGY; SKIN BURNING SENSATION; SKIN IRRITATION; SKIN MANIFESTATION; SKIN SENSATION; SKIN TOXICITY; SYMPOSIUM; SYMPTOMATOLOGY; SYSTEMIC DISEASE; UNITED STATES;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; CLINICAL TRIALS; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; HUMANS; METRONIDAZOLE; PATIENT COMPLIANCE; ROSACEA; SULFACETAMIDE; SULFUR; SUNSCREENING AGENTS;

EID: 0347917033     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.1.5     Document Type: Review

References (46)

1. DEL ROSSO JQ. A status report on medical management of rosacea: focus on topical therapies. Cutis (2002) 70:271-275.
2. WILKIN J, DAHL M, DETMAR M et al.: Standard classification of rosacea: report of the National Rosacea Society Expert Committee on classification and staging of rosacea. J. Am. Acad. Dermatol. (2002) 46:584-587.
3. BAMFORD JTM: Rosacea: current thoughts on origin. Sem. Cut Med. Surg. (2001) 20:199-206.
4. DAHL MV: Pathogenesis of rosacea. Adv. Dermatol. (2001) 17:29-45.
5. DEL ROSSO JQ: Medical management of rosacea with topical agents: a thorough appraisal of available treatment options and recent advances. Cosm. Dermatol. (2003) 16:47-60.
6. MILLIKAN L: The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skin Med. (2003) 2:43-47.
7. WILKIN J: Rosacea: pathophysiology and treatment.Arch. Dermatol. (1994) 130:359-362.
8. WILKIN J: Why is flushing limited to a mostly facial distribution? J. Am. Acad. Dermatol. (1988) 19:309-313.
9. PARISH LC, WITKOWSI JA: Acne rosacea and Helicobacter pylori bethrothed. Int. J. Dermatol. (1995) 34:236-237.
10. SHARMA VK, LYNN A, KAMINSKI M et al.: A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am. J. Gastroenterol. (1998) 93:220-222.
11. AKAMATSU H, OGUCHI M, NISHIJIMA S et al.: The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid. a possible mechanism of action of metronidazole in rosacea and acne. Arch. Dermatol. Res. (1990) 282:449-454.
12. MCCLELLAN KJ, NOBLE S: Topical metronidazole: a review of its use in rosacea. Am. J. Clin. Dermatol. (2000) 1:191-199.
13. MADDIN S: A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. (1999) 40:961-965.
14. DAHL MV, JARRETT M, KAPLAN D et a.: Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J. Am. Acad. Dermatol. (2001) 45:723-730.
15. NIELSEN PG: A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br. J. Dermatol. (1983) 109:63-65.
16. MONK BE, LOGAN RA, COOK J et al.: Topical metronidazole in the treatment of rosacea. J. Dermatol. Treat. (1991) 2:91-93.
17. SCHACHTER D, SCHACHTER RK, LONG B et al.: Comparison of metronidazole 1% cream versus oral tetracycline in patients with rosacea. Drug Invest. (1991) 3:220-224.
18. VEIEN NK, CHRISTIANSEN JV, HJORTH N et al.: Topical metronidazole in the treatment of rosacea. Cutis (1986) 38:209-210.
19. DRENO B, DUBERTRET L, NAEYAERT JM et al: Comparison of the clinical efficacy and safety of metronidazole 0.75% cream with metronidazole 0.75% gel in the treatment of rosacea. J. Eur. Acad. Dermatol. Venerrol. (1998) ll:S272-S273.
20. GUILLET B, ROSTAIN E, POWELL F et al: Metronidazole 0,75% gel and lotion are both effective in the treatment of rosacea. J. Eur. Dermatol. Venereal. (1999) 2:S145.
21. DAHL MV, KATZ HI, KRUEGER GG et al.: Topical metronidazole maintains remission of rosacea. Arch. Dermatol. (1998) 134:679-683.
22. OLANSKY S: Old drug-in a new system-revisited. Cutis (1977) 19:852-854.
23. TARIMCI N, SENER S, KILINC T: Topical sodium sulfacetamide lotion. J. Clin. Pharm. Ther. (1997) 22:301.
24. SAUDER D, MILLER R. GRATTON D et al: The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion is demonstrated in a double-blind study. J. Dermatol. Treat. (1997) 8:79-85.
25. DAVIS GF, GLAZER SD, MEDANSKY RS: Successful treatment of rosacea with a novel formulation of sodium sulfacetamide 10% and sulfur 5% topical lotion. J. Geriatr. Dermatol (1994) 2:140-144.
26. LEBWOHL MG, MEDANSKY RS, RUSSO CL et al.: The comparative efficacy of sodium sulfacetamide 10%/sulfur 5% lotion and metronidazole 0.75% gel in the treatment of rosacea. J. Dermatol. Treat. (1995) 3:183-185.
27. DEL ROSSO JQ. Therapeutic cleansers: keeping it clean. Skin Aging (2003) 11:83-88.
28. CARMICHAEL AJ, MARKS R, GRAUPE KA et al.: Topical azelaic acid in the treatment of rosacea. J. Dermatol. Treat. (1993) 4:SI9-S22.
29. BJERKE R, FRYAND O, GRAUPE K: Double-blind comparison of azelaic acid 20% cream and its vehicle in the treatment of papulopustular rosacea. Acta Derm. Venereol (1999) 79:456-459.
30. AKAMATSU H, KOMURA J, ASADA Y et al.: Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch. Dermatol. Res. (1991) 283:162-166.
31. DRAELOS ZD, GRAUPE K: A new topical formulation for the treatment of mild to moderate papulopustular rosacea: azelaic acid 15% gel. American Academy of Dermatology 61st Annual Meeting, San Francisco, California, USA. March 21 - 26 (2003) (Poster #49).
32. THIBOUTOT D, THIEROFF-EKERDT R, GRAUPE K: Efficacy and safety of azelaic acid 15% gel as a new treatment for papulopustular rosacae: results from two-vehicle controlled, randomized Phase III studies. J. Am. Acad. Dermatol. (2003) 48:836-845.
33. ELEWSKI BE: A comparison of topical azelaic acid 15% gel and metronidazole 0.75% gel in the treatment of papulopustular facial rosacea: results of a 15-week, randomized, double-blind, multicenter study. American Academy of Dermatology, 61st Annual Meeting, San Francisco, California, USA. March 21 - 26, (2003) (Poster#50).
34. WILKIN JK, DEWITT S: Treatment of rosacea: topical clindamycin versus oral tetracycline. Int. J. Dermatol. (1993) 32:65-67.
35. MILLS OH, KLIGMAN AA. Topically applied erythromycin in rosacea. Arch. Dermatol. (1976) 112:553-554.
36. BERTH-JONES J, CLARK SM, HENDERSON CA. Rosacea and perioral dermatitis. In: Treatment of skin disease. Lebwohl M, Heymann WR, Berth-Jones J, Coulson I (Eds), Mosby, London, UK (2002):561-567.
37. BIKOWSKI JB: Rosacea: a tiered approach to therapy. Cutis (2000) 66:S3-S6.
38. DEL ROSSO JQ: Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis (2000) 66:S7-S13.
39. JORIZZO JL, LEBWOHL M, TOBEY RE: The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial.J. Am. Acad. Dermatol. (1998) 39:502-504.
40. BRENEMAN DL, STEWART D, HEVIA O et al.: A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis (1998) 61:44-47.
41. TAN JKL, GIRARD C, KROLA et al.: Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea. J. Cutan. Med. Surg. (2002) 6:529-534.
42. KNIGHT AG, VICKERS CF: A follow-up of tetracycline-treated rosacea with special reference to rosacea keratitis. Br. J. Dermatol. (1975) 93:577-580.
43. VIENNE MP, OCHANDO N, BORREL MT et al.: Retinaldehyde alleviates rosacea. Dermatology (1999) 1999:53-56.
44. NICHOLS K, DESAI N, LEBWOHL MG: Effective sunscreen ingredients and cutaneous irritation in patients with rosacea. Cutis (1998) 61:344-346.
45. BIKOWSKI JB: Subantimicrobial dose doxycycline for acne and rosacea. Skin Med. (2003) 2:234-245.
46. SKIDMORE RA, WALKER C, KOVACH R et al.: Effects of a subantimicrobial dose of doxycycline in the treatment of moderate acne. Arch. Dermatol. (2003) 139:459-464.